BridgeBio Pharma, Inc. (BBIO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-12
07:32 am
Purchase
2026-09-3013GBRIDGEBIO PHARMA INC
BBIO
Farallon Capital Management, L.L.C.14,247,000
7.300%
3,503,937increase
(+32.62%)
Filing
History
2026-10-27
5:25 pm
Purchase
2026-09-3013GBRIDGEBIO PHARMA INC
BBIO
BlackRock Inc.
BLK
9,892,226
5.100%
158,464increase
(+1.63%)
Filing
History
2026-08-17
5:30 pm
Sale
2026-08-1313DBRIDGEBIO PHARMA INC
BBIO
KKR Genetic Disorder L.P.9,232,739
4.700%
-4,028,232decrease
(-30.38%)
Filing
History
2026-08-03
08:31 am
Purchase
2026-06-3013GBRIDGEBIO PHARMA INC
BBIO
Farallon Capital Management, L.L.C.10,743,063
5.500%
10,743,063increase
(New Position)
Filing
History
2026-07-27
4:25 pm
Sale
2026-06-3013GBRIDGEBIO PHARMA INC
BBIO
BlackRock Inc.
BLK
9,733,762
4.960%
-3,145,077decrease
(-24.42%)
Filing
History
2026-07-10
7:03 pm
Sale
2026-07-0913DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP9,792,219
5.000%
-2,050,215decrease
(-17.31%)
Filing
History
2026-05-29
4:48 pm
Purchase
2026-05-2213GBRIDGEBIO PHARMA INC
BBIO
Farallon Capital Partners, L.P.10,226,063
5.200%
10,226,063increase
(New Position)
Filing
History
2026-05-15
12:36 pm
Purchase
2026-03-3113GBRIDGEBIO PHARMA INC
BBIO
Janus Henderson Group Ltd.
JHG
13,179,013
6.800%
2,178,556increase
(+19.80%)
Filing
History
2026-04-16
4:35 pm
Sale
2026-03-3113GBRIDGEBIO PHARMA INC
BBIO
Kumar Neil9,282,982
4.600%
-1,183,730decrease
(-11.31%)
Filing
History
2026-04-02
6:40 pm
Sale
2026-03-3113DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP11,842,434
6.100%
-1,183,933decrease
(-9.09%)
Filing
History
2026-03-26
4:41 pm
Sale
2026-03-1313GBRIDGEBIO PHARMA INC
BBIO
VANGUARD GROUP INC0
0.000%
-16,484,985decrease
(Position Closed)
Filing
History
2026-02-17
8:46 pm
Sale
2026-02-1213DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP13,026,367
6.800%
-2,867,567decrease
(-18.04%)
Filing
History
2026-02-17
12:43 pm
Purchase
2025-12-3113GBRIDGEBIO PHARMA INC
BBIO
Janus Henderson Group Ltd.
JHG
11,000,457
5.700%
11,000,457increase
(New Position)
Filing
History
2025-11-14
4:52 pm
Sale
2025-11-1413DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP15,893,934
8.200%
-2,708,986decrease
(-14.56%)
Filing
History
2025-11-14
12:19 pm
Purchase
2025-09-3013GBRIDGEBIO ONCOLOGY THERAPEUTIC
BBOT
T. Rowe Price Associates, Inc.885,042
1.100%
885,042increase
(New Position)
Filing
History
2025-08-14
8:32 pm
Unchanged
2025-08-1413DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP18,602,920
9.700%
0
(Unchanged)
Filing
History
2025-07-29
11:20 am
Purchase
2025-06-3013GBRIDGEBIO PHARMA INC
BBIO
VANGUARD GROUP INC16,484,985
8.680%
3,684,691increase
(+28.79%)
Filing
History
2025-07-01
7:49 pm
Sale
2025-06-2713DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP18,602,920
9.800%
-3,452,455decrease
(-15.65%)
Filing
History
2025-05-14
5:52 pm
Sale
2025-05-1213DBRIDGEBIO PHARMA INC
BBIO
KKR Genetic Disorder L.P.13,260,971
7.000%
-6,000,000decrease
(-31.15%)
Filing
History
2025-03-12
4:28 pm
Unchanged
2025-01-3113DBRIDGEBIO PHARMA INC
BBIO
VIKING GLOBAL INVESTORS LP22,055,375
11.700%
0
(Unchanged)
Filing
History
Goto 0, 1, 2, Next